Alberto Garcia-Basteiro
@agbasteiro.bsky.social
990 followers 1.8K following 40 posts
Medical epidemiologist @manhica_CISM + @ISGlobalorg + @hospitalclinic + @UniBarcelona Tuberculosis / Epidemiology / Vaccines / Global Health
Posts Media Videos Starter Packs
Reposted by Alberto Garcia-Basteiro
mtbi.bsky.social
🚨 Exciting global health opportunity!
@isglobal.org is hiring a Medical Research Fellow (Tuberculosis) in Manhiça, Mozambique.

Lead impactful TB research with a top team.
🩺 MD + 4yrs clinical exp
🗓️ 2-yr contract
🔗 Apply: jobs.isglobal.org/jobs/6376227

#GlobalHealth #TB #ResearchJobs #PublicHealth
Medical Research Fellow, Area of Tuberculosis - Barcelona Institute for Global Health (ISGlobal)
The Barcelona Institute for Global Health (ISGlobal) is a cutting-edge institute addressing global public health challenges through research, translation into policy and education. ISGlobal has a b...
jobs.isglobal.org
Reposted by Alberto Garcia-Basteiro
kchorton.bsky.social
In our latest personal view in @lancetrespirmed.bsky.social, we argue for the inclusion asymptomatic #tuberculosis in vaccine trial endpoints to potentially reduce the size, length, and cost of trials.

doi.org/10.1016/S221...

@lshtm-tbmod.bsky.social @tb-lshtm.bsky.social
Figure 1. Estimated number of trial endpoints in the control group of a prevention-of-disease vaccine trial in a high disease-burden setting showing number of endpoints on the y-axis and time in months on the x-axis. For bacteriologically confirmed symptomatic tuberculosis disease endpoints only, we estimate 69 endpoints, and for combined bacteriologically confirmed asymptomatic and symptomatic tuberculosis disease endpoints, we estimate 151 endpoints. Scenario assumes symptomatic disease incidence before trial screening of 300/100 000 per year and following 10 000 individuals over 3 years. Prevalent symptomatic and asymptomatic tuberculosis disease are screened out in month 0 and are not trial endpoints. Active screening occurs every 6 months for both scenarios and participants self-presenting with symptoms suggestive of tuberculosis disease would also be investigated.
Reposted by Alberto Garcia-Basteiro
mtbi.bsky.social
💥Today we share great news! @agbasteiro.bsky.social has been honored with the XX Banc Sabadell Foundation Award for Biomedical Research! 👏🏾

🔗 fundacionbancosabadell.com/la-fundacion...

#PremiosBiomédicaCiencias #LaCulturadelTalento #Investigación
La Fundación Banco Sabadell premia dos investigadores por sus trabajos sobre la tuberculosis y sobre el diseño computacional de enzimas - Fundación Banco Sabadell
fundacionbancosabadell.com
Reposted by Alberto Garcia-Basteiro
isglobal.org
Deben participar las personas encarceladas en ensayos de vacunas contra la #TB?

"Hay que garantizar ensayos seguros y éticos para una vacuna que podría proteger su salud y la de sus familias", dice @agbasteiro.bsky.social.

#EndTB
Ensayos de vacunas en prisiones - ISGLOBAL
Sobre el derecho de las personas privadas de libertad a participar en investigaciones biomédicas, siempre que se respete su autonomía y sus derechos
f.mtr.cool
agbasteiro.bsky.social
Great collaborative piece with top experts in the field of #TB in prisons @jasonandrews.bsky.social @juliocroda.bsky.social and other renown epidemiologists!
Roda (@roda.bsky.social)
roda.bsky.social
agbasteiro.bsky.social
We just published a piece about the participation of people deprived of liberty in #tuberculosis vaccine trials. Should they be protected from research, or through research?

www.thelancet.com/journals/lan...

@thelancetinfdis.bsky.social @isglobal.org @mtbi.bsky.social
Reposted by Alberto Garcia-Basteiro
mtbi.bsky.social
#MTBI was proud to join the 12th #EDCTP Forum last week in Kigali, Rwanda. The event brought together global leaders to advance clinical research and partnerships in sub-Saharan Africa. A great opportunity to connect, share insights, and support better health through global collaboration.
agbasteiro.bsky.social
I am grateful for the opportunity to present at the #EDCTPforum in Kigali. We had a great session on #Tuberculosis prediction and early TB trajectories, with Shima Abdulgader and Edson Marambire. Chaired by @kkranzer.bsky.social & @willyssengooba.bsky.social
agbasteiro.bsky.social
Great opening ceremony of the #EDCTPforum in Kigali, Rwanda 🇷🇼 Excited to be here and meet many colleagues and friends.

Presenting this upcoming Tuesday on the science of #tuberculosis prediction

@isglobal.org @mtbi.bsky.social @ub.edu
Reposted by Alberto Garcia-Basteiro
mtbi.bsky.social
#MTBI members Dr. Lucía Carratalá & @joannaehrlich.bsky.social ‪joined other colleagues to present updates on the final key study results, main indicators & data management.

👏A great opportunity to showcase the hard work behind Impactful research on the advances in TB diagnostics.

#endTB #Stool4TB
Reposted by Alberto Garcia-Basteiro
mtbi.bsky.social
The #Stool4TB Consortium Annual Meeting in Eswatini kicked off with opening remarks from Dr. @agbasteiro.bsky.social, PI of the #MTBI initiative, and Ms. Rejoice Nkambule, Deputy Director of Public Health at Eswatini’s Ministry of Health.
Reposted by Alberto Garcia-Basteiro
mtbi.bsky.social
This achievement highlights the power of collaboration, innovation, and commitment to advancing global health.

#Stool4TB focuses on validating a qPCR stool-based test designed to improve TB diagnosis in children and people living with HIV.

🔗 Learn more: www.stool4tb.org
(Stool4TB)
www.stool4tb.org
Reposted by Alberto Garcia-Basteiro
mtbi.bsky.social
✨The final annual meeting of the #Stool4TB Consortium in Mbabane, Eswatini, was a great success — marking the conclusion of five years of collaborative research to improve tuberculosis diagnosis.
Partners from across Eswatini, Uganda, and Mozambique came together to celebrate a major milestone!
agbasteiro.bsky.social
Today @prados-rosales.bsky.social came to visit us. His presentation on extracellular vesicles for #TB diagnosis was extremely interesting and engaging. Come back soon Rafa!!

@mtbi.bsky.social @isglobal.org
Reposted by Alberto Garcia-Basteiro
mtbi.bsky.social
🟡 We're pleased to be participating in the TBnet Academy in Tirana this week!

📸 Today, Dr. @agbasteiro.bsky.social delivered a talk on Asymptomatic Tuberculosis, sharing insights on one of the most challenging aspects of TB control.

#TBnetAcademy #endTB #MTBI
Reposted by Alberto Garcia-Basteiro
isglobal.org
Alberto García-Basteiro (@agbasteiro.bsky.social) has been recognised as a “Fellow” by the European Respiratory Society — one of the highest honours in the field of respiratory medicine. 👏 Congratulations, Alberto!

🟠 www.isglobal.org/en/-/alberto...
agbasteiro.bsky.social
I am happy to share this piece about "Transforming partnerships through transboundary research" published in BMJ Global Health.

It addresses the structural asymmetries that continue to affect collaborations in global health

@isglobal.bsky.social @mtbi.bsky.social

gh.bmj.com/content/bmjg...
Reposted by Alberto Garcia-Basteiro
mtbi.bsky.social
👏🏾 El debate de ayer de #CaixaResearch sobre #Tuberculosis fue imprescindible. La enfermedad infecciosa más mortal del mundo fue analizada en profundidad por @agbasteiro.bsky.social, @pjcardona14.bsky.social e Iñaki Comas.

➡️ Si te lo perdiste, aún puedes verlo: www.youtube.com/watch?v=USQv...
Reposted by Alberto Garcia-Basteiro
mtbi.bsky.social
❗Hoy participamos en un debate de Caixa Research sobre #TB.
Estará uno de nuestros PI @agbasteiro.bsky.social, junto con @pjcardona14.bsky.social e Iñaki Comas, con la moderadora Jessica Mouzo.

¡No os lo perdáis!
Apúntate: caixaresearch.org/es/debates-c...

#endTB #MTBI #CaixaResearch
Reposted by Alberto Garcia-Basteiro
mtbi.bsky.social
💥 Today we are reminded that TB is one of the deadliest infectious diseases worldwide. Despite being preventable and curable, millions of people still suffer from its effects.
MTBI is committed to improving TB diagnosis, treatment, and prevention to move closer to its eradication.
#endTB #WorldTBDay